Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells
Jinjong Myoung, Don Ganem
Jinjong Myoung, Don Ganem
Published February 21, 2011
Citation Information: J Clin Invest. 2011;121(3):1130-1140. https://doi.org/10.1172/JCI43755.
View: Text | PDF
Research Article Article has an altmetric score of 1

Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells

  • Text
  • PDF
Abstract

Kaposi sarcoma–associated herpesvirus (KSHV) is a B-lymphotropic virus whose primary site of replication is the oropharynx. KSHV can infect both T and B cells from primary tonsillar explant cultures. However, T cells do not support lytic replication, while B cells spontaneously produce substantial amounts of infectious virus. Here, we provide evidence for a mechanism by which activated T cells may promote or stabilize latency of KSHV infection in B cells. When mixed cultures of B cells and activated T cells were exposed to KSHV, little spontaneous virus production was observed. Removing T cells from the mix or treating the mixed culture with immune suppressants enhanced virus production. Adding back activated T cells to purified infected B cells efficiently suppressed KSHV production, primarily due to CD4+ T cells. This suppressive activity required T cell activation and direct cell-cell contact, but not prior exposure to KSHV antigen. Suppression was not MHC restricted and did not result in killing of the target cell. We therefore propose that oropharyngeal T cells activated by a variety of stimuli can recognize ligands on infected target B cells, leading to signaling events that prevent spontaneous lytic activation and promote latent infection in this compartment.

Authors

Jinjong Myoung, Don Ganem

×

Total citations by year

Year: 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 Total
Citations: 2 3 1 6 3 4 3 4 1 5 5 2 3 42
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (42)

Title and authors Publication Year
Kaposi’s Sarcoma-Associated Herpesvirus Immediate Early Proteins Trigger FOXQ1 Expression in Oral Epithelial Cells, Engaging in a Novel Lytic Cycle-Sustaining Positive Feedback Loop
Atyeo N, Chae MY, Toth Z, Sharma A, Papp B
Journal of virology 2023
Macrophages drive KSHV B cell latency
Szymula A, Samayoa-Reyes G, Ogolla S, Liu B, Li S, George A, Van Sciver N, Rochford R, Simas JP, Kaye KM
Cell Reports 2023
Polyamine biosynthesis and eIF5A hypusination are modulated by the DNA tumor virus KSHV and promote KSHV viral infection
G Fiches, Z Wu, D Zhou, A Biswas, T Li, W Kong, M Jean, N Santoso, J Zhu, F Zhu
PLoS pathogens 2022
RNA Granules in Antiviral Innate Immunity: A Kaposi's Sarcoma-Associated Herpesvirus Journey.
Sharma NR, Zheng ZM
Frontiers in microbiology 2022
The ORF45 Protein of Kaposi’s Sarcoma-Associated Herpesvirus and Its Critical Role in the Viral Life Cycle
Atyeo N, Papp B
Viruses 2022
Kaposi's sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda.
Nalwoga A, Roshan R, Moore K, Marshall V, Miley W, Labo N, Nakibuule M, Cose S, Rochford R, Newton R, Whitby D
Nature Communications 2021
Regulation of KSHV Latency and Lytic Reactivation
G Broussard, B Damania
Viruses 2020
Molecular Virology of KSHV in the Lymphocyte Compartment—Insights From Patient Samples and De Novo Infection Models
F Aalam, J Totonchy
Frontiers in Cellular and Infection Microbiology 2020
Analysis of KSHV B lymphocyte lineage tropism in human tonsil reveals efficient infection of CD138+ plasma cells
F Aalam, R Nabiee, JR Castano, J Totonchy, VL Tarakanova
PLoS pathogens 2020
Distinct genetic architectures and environmental factors associate with host response to the γ2-herpesvirus infections
N Sallah, W Miley, N Labo, T Carstensen, S Fatumo, D Gurdasani, MO Pollard, AT Dilthey, AJ Mentzer, V Marshall, EM Castro, C Pomilla, EH Young, G Asiki, ML Hibberd, M Sandhu, P Kellam, R Newton, D Whitby, I Barroso
Nature Communications 2020
Lymphotropic Viruses: Chronic Inflammation and Induction of Cancers
EW Harhaj, N Shembade
Biology : open access journal 2020
Sarcome de kaposi et myélome multiple: s´agit-il d´une association causée par le HHV-8?
S Kahouli, H Zahid, M Benkirane, N Messaoudi
The Pan African medical journal 2020
Cell Type-Specific Interferon-γ-mediated Antagonism of KSHV Lytic Replication
MK Park, H Cho, SW Roh, SJ Kim, J Myoung
Scientific Reports 2019
How Kaposi’s sarcoma-associated herpesvirus stably transforms peripheral B cells towards lymphomagenesis
A Faure, M Hayes, B Sugden
Proceedings of the National Academy of Sciences 2019
Towards Understanding KSHV Fusion and Entry
SJ Dollery
Viruses 2019
LL-37 disrupts the Kaposi's sarcoma-associated herpesvirus envelope and inhibits infection in oral epithelial cells
DC Brice, Z Toth, G Diamond
Antiviral Research 2018
KSHV induces immunoglobulin rearrangements in mature B lymphocytes
J Totonchy, JM Osborn, A Chadburn, R Nabiee, L Argueta, G Mikita, E Cesarman, L Coscoy
PLoS pathogens 2018
Kaposi’s Sarcoma-Associated Herpesvirus-Encoded Viral IL-6 (vIL-6) Enhances Immunoglobulin Class-Switch Recombination
SA Rosario, GE Santiago, EA Mesri, RE Verdun
Frontiers in microbiology 2018
Glycoprotein K8.1A of Kaposi's Sarcoma-Associated Herpesvirus Is a Critical B Cell Tropism Determinant Independent of Its Heparan Sulfate Binding Activity
SJ Dollery, RJ Santiago-Crespo, D Chatterjee, EA Berger, RM Longnecker
Journal of virology 2018
Reactivation and Lytic Replication of Kaposi’s Sarcoma-Associated Herpesvirus: An Update
Y Yuan, KK Aneja
Frontiers in microbiology 2017
Primary lymphocyte infection models for KSHV and its putative tumorigenesis mechanisms in B cell lymphomas
S Kang, J Myoung
The Journal of Microbiology 2017
Comment on primary lymphocyte infection models for KSHV and its putative tumorigenesis mechanisms in B cell lymphomas (Journal of Microbiology 2017, 55(5): 319-329)
G Rappocciolo, F Jenkins, CR Rinaldo
The Journal of Microbiology 2017
Primary B Lymphocytes Infected with Kaposi's Sarcoma-Associated Herpesvirus Can Be Expanded In Vitro and Are Recognized by LANA-Specific CD4 + T Cells
SM Nicol, S Sabbah, KF Brulois, JU Jung, AI Bell, AD Hislop, K Frueh
Journal of virology 2016
IκB Kinase ε Is an NFATc1 Kinase that Inhibits T Cell Immune Response
J Zhang, H Feng, J Zhao, ER Feldman, SY Chen, W Yuan, C Huang, O Akbari, SA Tibbetts, P Feng
Cell Reports 2016
An EBV recombinant deleted for residues 130-159 in EBNA3C can deregulate p53/Mdm2 and Cyclin D1/CDK6 which results in apoptosis and reduced cell proliferation
SK Shukla, HC Jha, DW El-Naccache, ES Robertson
Oncotarget 2016
KSHV Entry and Trafficking in Target Cells—Hijacking of Cell Signal Pathways, Actin and Membrane Dynamics
B Kumar, B Chandran
Viruses 2016
Gammaherpesvirus Infection of Human Neuronal Cells
HC Jha, D Mehta, J Lu, D El-Naccache, SK Shukla, C Kovacsics, D Kolson, ES Robertson
mBio 2015
Kaposi’s Sarcoma-Associated Herpesvirus Genome Programming during the Early Stages of Primary Infection of Peripheral Blood Mononuclear Cells
HC Jha, J Lu, SC Verma, S Banerjee, D Mehta, ES Robertson
mBio 2014
Enhanced Response of T Cells from Murine Gammaherpesvirus 68-Infected Mice Lacking the Suppressor of T Cell Receptor Signaling Molecules Sts-1 and Sts-2
B Cieniewicz, N Carpino, LT Krug, DA Leib
PloS one 2014
Human Viral Oncogenesis: A Cancer Hallmarks Analysis
EA Mesri, MA Feitelson, K Munger
Cell Host & Microbe 2014
Oncogenes and RNA splicing of human tumor viruses
M Ajiro, ZM Zheng
Emerging Microbes & Infections 2014
Dendritic cells: key players in human herpesvirus 8 infection and pathogenesis
DM Campbell, G Rappocciolo, FJ Jenkins, CR Rinaldo
Frontiers in microbiology 2014
Professional antigen presenting cells in human herpesvirus 8 infection
ER Knowlton, LM Lepone, J Li, G Rappocciolo, FJ Jenkins, CR Rinaldo
Frontiers in immunology 2013
Evasion of adaptive and innate immune response mechanisms by γ-herpesviruses
P Feng, A Moses, K Früh
Current Opinion in Virology 2013
Kaposi's sarcoma-associated herpesvirus ORF57 protein: exploiting all stages of viral mRNA processing
S Schumann, BR Jackson, B Baquero-Perez, A Whitehouse
Viruses 2013
Efficient infection of a human B cell line with cell-free Kaposi's sarcoma-associated herpesvirus
SJ Dollery, RJ Santiago-Crespo, L Kardava, S Moir, EA Berger
Journal of virology 2013
Abortive lytic reactivation of KSHV in CBF1/CSL deficient human B cell lines
BA Scholz, ML Harth-Hertle, G Malterer, J Haas, J Ellwart, TF Schulz, B Kempkes
PLoS pathogens 2013
Human Herpesvirus 8 (HHV8) Sequentially Shapes the NK Cell Repertoire during the Course of Asymptomatic Infection and Kaposi Sarcoma
S Dupuy, M Lambert, D Zucman, SP Choukem, S Tognarelli, C Pages, C Lebbé, S Caillat-Zucman
PLoS pathogens 2012
The RBP-Jκ Binding Sites within the RTA Promoter Regulate KSHV Latent Infection and Cell Proliferation
J Lu, SC Verma, Q Cai, A Saha, RK Dzeng, ES Robertson
PLoS pathogens 2012
Unravelling Virus-Induced Lymphomagenesis
Chris Boshoff
Journal of Clinical Investigation 2011
Infection of Lymphoblastoid Cell Lines by Kaposi's Sarcoma-Associated Herpesvirus: Critical Role of Cell-Associated Virus
J Myoung, D Ganem
Journal of virology 2011
Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction
J Myoung, D Ganem
Journal of Virological Methods 2011

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Highlighted by 1 platforms
37 readers on Mendeley
See more details